Big Pharma has been criticized for making deals that may bring harm to shareholder interests. Evaluate the following transaction from earnings management and ethical perspectives: A pharmaceutical drug company agreed to make payments to wholesalers if they bought drugs they did not need. The company paid $66 million to wholesalers who then "bought" $720 million of the company's drugs for which no customers existed.